Search

Search Constraints

You searched for: Author/Creator Ginard, D

Search Results

2. Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU. (27th May 2021)

3. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Issue 10 (24th June 2010)

4. OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study. (27th May 2021)

5. OP29 Tofacitinib in ulcerative colitis: Real-world evidence from Eneida Registry. (15th January 2020)

6. P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease. (30th January 2023)

7. P185 Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. (27th May 2021)

8. P257 Surgical and hospital admission in adults newly diagnosed with inflammatory bowel disease (IBD) in the biological era in Spain: Results of the nationwide EpidemIBD study of GETECCU. (16th January 2018)

9. P263 Influence of Crohn′s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study. (27th May 2021)

10. P423 Epidemiology, diagnostic work-up and pharmacological requirements of inflammatory bowel disease (IBD) in Spain: Results from the nationwide EpidemIBD study of GETECCU. (16th January 2018)